BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roy I, Getschman AE, Volkman BF, Dwinell MB. Exploiting agonist biased signaling of chemokines to target cancer. Mol Carcinog 2017;56:804-13. [PMID: 27648825 DOI: 10.1002/mc.22571] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Larsen O, van der Velden WJC, Mavri M, Schuermans S, Rummel PC, Karlshøj S, Gustavsson M, Proost P, Våbenø J, Rosenkilde MM. Identification of a conserved chemokine receptor motif that enables ligand discrimination. Sci Signal 2022;15:eabg7042. [PMID: 35258997 DOI: 10.1126/scisignal.abg7042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wang K, Li R, Zhang Y, Qi W, Fang T, Yue W, Tian H. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma. IJGM 2022;Volume 15:2283-300. [DOI: 10.2147/ijgm.s352511] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Karin N. Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones? Cancers (Basel) 2021;13:6317. [PMID: 34944943 DOI: 10.3390/cancers13246317] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
4 Kong W, Zhao G, Chen H, Wang W, Shang X, Sun Q, Guo F, Ma X. Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment. Cancer Cell Int 2021;21:399. [PMID: 34321012 DOI: 10.1186/s12935-021-02101-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
5 van Gastel J, Leysen H, Boddaert J, Vangenechten L, Luttrell LM, Martin B, Maudsley S. Aging-related modifications to G protein-coupled receptor signaling diversity. Pharmacol Ther 2021;223:107793. [PMID: 33316288 DOI: 10.1016/j.pharmthera.2020.107793] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Zeng Q, Sun S, Li Y, Li X, Li Z, Liang H. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment. Front Oncol 2019;9:1555. [PMID: 32117786 DOI: 10.3389/fonc.2019.01555] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 23.5] [Reference Citation Analysis]
7 Shukla AK, Dwivedi-Agnihotri H. Structure and function of β-arrestins, their emerging role in breast cancer, and potential opportunities for therapeutic manipulation. Adv Cancer Res 2020;145:139-56. [PMID: 32089163 DOI: 10.1016/bs.acr.2020.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Kenakin T, Barker EL. Biased Receptor Signaling in Drug Discovery. Pharmacol Rev 2019;71:267-315. [DOI: 10.1124/pr.118.016790] [Cited by in Crossref: 141] [Cited by in F6Publishing: 143] [Article Influence: 47.0] [Reference Citation Analysis]
9 Ulrich H, Ratajczak MZ, Schneider G, Adinolfi E, Orioli E, Ferrazoli EG, Glaser T, Corrêa-Velloso J, Martins PCM, Coutinho F, Santos APJ, Pillat MM, Sack U, Lameu C. Kinin and Purine Signaling Contributes to Neuroblastoma Metastasis. Front Pharmacol 2018;9:500. [PMID: 29867502 DOI: 10.3389/fphar.2018.00500] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
10 Edderkaoui B. Potential Role of Chemokines in Fracture Repair. Front Endocrinol (Lausanne) 2017;8:39. [PMID: 28303118 DOI: 10.3389/fendo.2017.00039] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 6.6] [Reference Citation Analysis]